Tango Therapeutics TNGX Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tango Therapeutics's common stock, par value (in dollars per share)?
- Tango Therapeutics (TNGX) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has Tango Therapeutics's common stock, par value (in dollars per share) changed year-over-year?
- Tango Therapeutics's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Tango Therapeutics's common stock, par value (in dollars per share)?
- Over 5 years (2020 to 2025), Tango Therapeutics's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.